Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

By Crowe J.E.   Bui P.T.   Siber G.R.   Elkins W.R.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 847-855

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV

By Xu W.   Hofmann-Lehmann R.   McClure H.M.   Ruprecht R.M.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1956-1960

Elsevier

Access to resources Recommend Favorite

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

By Iqbal M.   Lin W.   Jabbal-Gill I.   Davis S.S.   Steward M.W.   Illum L.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1478-1485

Elsevier

Access to resources Recommend Favorite

Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

By Staropoli I.   Frenkiel M.-P.   Megret F.   Deubel V.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1946-1954

Elsevier

Access to resources Recommend Favorite